SectorBiological Technology
Established Date21/02/2012
Listing Date18/09/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees187
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressZernikedreef 9, 2333 CK Leiden, The Netherlands
Business
IntroductionProQR Therapeutics N.V. is a limited liability company established in the Netherlands on February 21, 2012. The company is a biotechnology company dedicated to creating transformative RNA therapies to improve the lives of patients and families affected by diseases with high unmet medical needs. To achieve this goal, the company is advancing its proprietary Axiomer RNA editing platform technology. The Company's product candidates are designed to utilize adenosine deaminase for targeted RNA editing (" ADAR "), which the Company believes has the potential to become a new class of innovative drugs for a wide range of therapeutic areas.
